Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Julia SeegerJochen WöhrleBruno SchellerAhmed FarahMarc-Alexander OhlowNorman MangnerSven Möbius-WinklerDaniel WeilenmannGeorg StachelGregor LeibundgutPeter RickenbacherMarco CattaneoNicole GilgenChristoph KaiserRaban V Jegernull On Behalf Of The Basket-Small InvestigatorsPublished in: Journal of cardiovascular development and disease (2023)
DCB compared to DES for treatment of de novo coronary lesions in diabetic patients was associated with similar rates of MACE and numerically lower need for TVR both for ITDM and NITDM patients.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- type diabetes
- newly diagnosed
- end stage renal disease
- phase iii
- glycemic control
- coronary artery bypass grafting
- ejection fraction
- phase ii
- st segment elevation myocardial infarction
- chronic kidney disease
- acute coronary syndrome
- acute myocardial infarction
- clinical trial
- double blind
- antiplatelet therapy
- open label
- cardiovascular events
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- placebo controlled
- st elevation myocardial infarction
- patient reported outcomes
- adipose tissue
- cardiovascular disease
- insulin resistance